Chinese drug candidate secures FDA fast track status

YN003 injection, an innovative therapy built on China's self-developed active targeted nano drug delivery platform, has been granted Fast Track designation by the US Food and Drug Administration for treating adult glioma patients, including those with glioblastoma.

Raccontata daglobal.chinadaily.com.cn